Your session is about to expire
← Back to Search
IOP Response Monitoring for Glaucoma
Study Summary
This trial will study the changes caused by intraocular pressure in subjects with keratoconus in order to improve our understanding of the role of the lamina in glaucoma pathogenesis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have diabetes with eye damage.I have not had eye surgery or injury, except for laser treatments or successful cataract surgery over 6 months ago.I have signs of glaucoma in my optic nerve.I have an eye condition that is not related to glaucoma.My cornea is thinner in the center.I have been diagnosed with keratoconus.I do not have eye conditions like strabismus or nystagmus that affect my vision.I have cloudiness in parts of my eye like the lens or cornea.My vision loss is not due to glaucoma but another neurological reason.
- Group 1: Subjects With Keratoconus
- Group 2: Subjects with Glaucoma
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this medical investigation still open to new participants?
"Per clinicaltrials.gov, this research trial is currently recruiting participants. It was first advertised on November 15th 2018, and the most recent update to its listing occurred on November 21st 2022."
Are there any eligibility criteria which must be met in order to participate in this clinical experiment?
"This litigation seeks 130 individuals aged 18-90 years old with glaucoma to participate in the study. Inclusion criteria include ability to give informed consent; clinical diagnosis of keratoconus, central thinning of cornea, abnormal posterior ectasia; Glaucomatous ONH abnormality such as rim thinning, notching and undermining (excavation); two consecutive abnormal SITA standard perimetry tests outside normal limits."
Is this experiment recruiting subjects aged 45 and over?
"As per the requirements for enrolment, eligible participants must be 18 years old at a minimum and no older than 90."
To what extent is this research involving participants?
"Right, the details available on clinicaltrials.gov attest to this trial's persistent search for participants. Initially posted in November of 2018 and updated just last month, it seeks 130 volunteers from a single location."
Share this study with friends
Copy Link
Messenger